Navigation Links
Scientists Spot Key to Cystic Fibrosis Infections
Date:12/16/2008

Targeting pigments in mucus could fight deadly,,bacteria in lungs

TUESDAY, Dec. 16 (HealthDay News) -- Blue-green pigments called phenazines that stain the mucus in the lungs of cystic fibrosis patients are signaling molecules that could spur dangerous infections, researchers say.

The pigments may enable infectious Pseudomonas aeruginosa bacteria to form into structured communities, according to a Massachusetts Institute of Technology (MIT) study.

The finding could lead to the development of drugs that target phenazines to treat P. aeruginosa infections in CF patients, said the researchers, who presented their findings Tuesday at the annual meeting of the American Society for Cell Biology.

Healthy people can easily cope with P. aeruginosa, but it's the leading cause of death among CF patients, because it chokes their lungs with sticky mucus.

It's long been believed that phenazines were antibiotics, generated by P. aeruginosa to kill off its bacterial competitors in the lungs.

In laboratory studies, the MIT researchers found that phenazines create a smooth biofilm surface under which a P. aeruginosa colony can thrive. The less phenazine there is, the weaker the colony surface.

"We have a long way to go before being able to test this idea, but the hope is that if survival in the lung is influenced by phenazine -- or some other electron-shuttling molecule or molecules -- tampering with phenazine trafficking might be a potential way to make antibiotics more effective," study leader Dianne K. Newman, a professor of biology and geobiology, explained in an MIT news release.

More information

The March of Dimes has more about cystic fibrosis.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, Dec. 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists, Physicians, Health, and Environmental Justice Advocates to New Obama EPA Director: We Look Forward to Toxic Chemical Regulatory Reform
2. Seven life scientists get research boost to set up in Europe
3. UC San Diego scientists developing brain imaging methods for studying natural human behavior
4. Scientists ID Enzyme Causing Brain Cell Death
5. NASA scientists provide update on existing remote sensing technology programs and new projects
6. Scientists ID Protein Aiding Breast Cancer Spread
7. UCLA scientists prove endothelial cells give rise to blood stem cells
8. Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs
9. CSHL scientists show how a protein that determines cell polarity prevents breast cancer
10. Carnegie Mellon scientists offer explanation for face blindness
11. Scientists ID Uterine Muscle Switch for Contractions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Spot Key to Cystic Fibrosis Infections
(Date:9/21/2017)... Va. (PRWEB) , ... September 21, 2017 , ... ... with a different approach to addiction recovery at a time when Virginia faces ... deaths resulting from drug overdose, a staggering increase of 38 percent from 2015, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... the acquisition of Isle at Kingwood Assisted Living and Memory Care located at ... retirement community with 55 assisted living apartments, 43 memory care apartments and 23 ...
(Date:9/21/2017)... ... September 21, 2017 , ... In ... and Clark College Emeritus Professor of Education Gregory A. Smith examines student privacy ... Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of Policymaking . ...
(Date:9/20/2017)... CHARLOTTE, NC (PRWEB) , ... September 20, 2017 ... ... for Transformation and Centers of Excellence (CoE) with the latest Artificial Intelligence (AI) ... newly designed presence offers quick and easy access to essential information that offers ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... one of the Best Places to Work in the Research Triangle for 2017. ... Once nominated, a company had to meet a threshold in employee participation--a percentage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: